NCT00504829View on ClinicalTrials.gov

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

PHASE2CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

July 31, 2008

Conditions
Dyslipidemia
Interventions
DRUG

LCP-AtorFen

40mg atorvastatin combined with 100mg fenofibrate in a tablet for once daily treatment of dyslipidemia and mixed dyslipidemia

DRUG

atorvastatin

dyslipidemia and mixed dyslipidemia

DRUG

fenofibrate

dyslipidemia and mixed dyslipidemia

Trial Locations (1)

60610

Radiant Research, 515 N State Street, Suite 2700, Chicago

Sponsors
All Listed Sponsors
lead

Veloxis Pharmaceuticals

INDUSTRY